SI1410793T1 - Oblika dajanja ibuprofen-natrija - Google Patents

Oblika dajanja ibuprofen-natrija

Info

Publication number
SI1410793T1
SI1410793T1 SI200330125T SI200330125T SI1410793T1 SI 1410793 T1 SI1410793 T1 SI 1410793T1 SI 200330125 T SI200330125 T SI 200330125T SI 200330125 T SI200330125 T SI 200330125T SI 1410793 T1 SI1410793 T1 SI 1410793T1
Authority
SI
Slovenia
Prior art keywords
delivery form
sodium ibuprofen
ibuprofen
sodium
delivery
Prior art date
Application number
SI200330125T
Other languages
English (en)
Inventor
Peter Dr Gruber
Markus Dr Reher
Original Assignee
Bayer Consumer Care Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28796671&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI1410793(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Consumer Care Ag filed Critical Bayer Consumer Care Ag
Publication of SI1410793T1 publication Critical patent/SI1410793T1/sl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200330125T 2002-10-14 2003-04-03 Oblika dajanja ibuprofen-natrija SI1410793T1 (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH01703/02A CH693586A8 (de) 2002-10-14 2002-10-14 Darreichungsform von Ibuprofen-Natrium.
EP03405225A EP1410793B1 (de) 2002-10-14 2003-04-03 Darreichungsform von Ibuprofen-Natrium

Publications (1)

Publication Number Publication Date
SI1410793T1 true SI1410793T1 (sl) 2006-04-30

Family

ID=28796671

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200330125T SI1410793T1 (sl) 2002-10-14 2003-04-03 Oblika dajanja ibuprofen-natrija

Country Status (32)

Country Link
US (1) US20040102522A1 (sl)
EP (1) EP1410793B1 (sl)
JP (1) JP4608316B2 (sl)
KR (1) KR101046894B1 (sl)
CN (1) CN100592909C (sl)
AR (1) AR041428A1 (sl)
AT (1) ATE309789T1 (sl)
AU (1) AU2003266094B2 (sl)
BR (1) BRPI0315248B1 (sl)
CA (1) CA2500987A1 (sl)
CH (1) CH693586A8 (sl)
CO (1) CO5700709A2 (sl)
DE (1) DE50301661D1 (sl)
DK (1) DK1410793T3 (sl)
EA (1) EA007914B1 (sl)
EC (1) ECSP055793A (sl)
ES (1) ES2249702T3 (sl)
HR (1) HRP20050429A2 (sl)
IL (1) IL167357A (sl)
MA (1) MA27490A1 (sl)
MX (1) MXPA05003592A (sl)
MY (1) MY132858A (sl)
NO (1) NO20052343L (sl)
NZ (1) NZ539405A (sl)
PA (1) PA8586101A1 (sl)
PE (1) PE20040417A1 (sl)
PL (1) PL376177A1 (sl)
SI (1) SI1410793T1 (sl)
TW (1) TWI262800B (sl)
UA (1) UA86751C2 (sl)
WO (1) WO2004035024A1 (sl)
ZA (1) ZA200502925B (sl)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3920358A1 (de) * 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US6705028B2 (en) * 2001-09-12 2004-03-16 Honda Giken Kogyo Kabushiki Kaisha Self-propelled snowplow vehicle
US20050176809A1 (en) * 2004-02-05 2005-08-11 Rodlen Laboratories, Inc. Method and compositions for treatment of painful disorders
WO2006016125A1 (en) * 2004-08-12 2006-02-16 Reckitt Benckiser Healthcare (Uk) Limited Granules comprising a nsaid and a sugar alcohol made by melt extrusion
US20070077297A1 (en) * 2004-09-30 2007-04-05 Scolr Pharma, Inc. Modified release ibuprofen dosage form
WO2006093353A1 (ja) 2005-03-03 2006-09-08 Takeda Pharmaceutical Company Limited 放出制御組成物
US9205054B2 (en) 2005-03-22 2015-12-08 Losan Pharma Gmbh Solubilized ibuprofen
EP1800667A1 (en) 2005-12-23 2007-06-27 Losan Pharma GmbH Rapidly solubilizing ibuprofen granulate
DE102006029233A1 (de) * 2006-06-26 2007-12-27 Liedtke, Rainer K., Dr. Formulierungen zur Verbesserung der Verträglichkeit nichtsteroidaler Antiphlogistika
CL2007002425A1 (es) * 2006-08-22 2008-06-27 Albermarle Corp Procedimiento de preparacion controlado de sal sodica de ibuprofeno de tamano de particula mediano; y dichas particulas de sal sodica.
FI20080348A0 (fi) * 2008-02-15 2008-05-09 Atacama Labs Oy Uudenlainen farmaseuttinen formulaatio
US7749537B2 (en) * 2006-12-04 2010-07-06 Scolr Pharma, Inc. Method of forming a tablet
WO2010011522A1 (en) * 2008-07-21 2010-01-28 Albemarle Corporation High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US9629809B2 (en) 2008-07-21 2017-04-25 Si Group, Inc. High content sodium ibuprofen granules, their preparation and their use in preparing non-effervescent solid dosage forms
US20110144207A1 (en) * 2008-08-14 2011-06-16 Shasun Chemicals And Drugs Limited Aryl alkyl carboxylic acid salts, process for preparation and dosage forms
UA102128C2 (en) * 2008-12-05 2013-06-10 Х. Луннбек А/С Nalmefene hydrochloride dihydrate
AU2015264861C1 (en) * 2009-06-22 2017-11-16 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
AU2014200704C1 (en) * 2009-06-22 2018-12-06 Pf Consumer Healthcare 1 Llc Sodium ibuprofen tablets and methods of manufacturing pharmaceutical compositions including sodium ibuprofen
JP2012530781A (ja) * 2009-06-22 2012-12-06 ワイス・エルエルシー イブプロフェンナトリウムタブレット、およびイブプロフェンナトリウムを含有する医薬組成物の製造方法
FR2997856B1 (fr) * 2012-11-14 2015-04-24 Pf Medicament Pastille medicamenteuse a base d'ibuprofene sodique dihydrate
EP2965746B1 (en) 2014-07-10 2019-03-13 Santa Farma Ilaç Sanayi A.S. An oral pharmaceutical composition comprising ibuprofen, ibuprofen sodium dihydrate, pseudoephedrine hydrochloride and chlorpheniramine maleate
US20180078516A1 (en) * 2016-09-19 2018-03-22 Innovazone Labs LLC Pharmaceutical Composition of Ibuprofen Sodium for Oral Administration
CN113893227B (zh) * 2021-11-18 2023-04-14 山东则正医药技术有限公司 布洛芬片的制备原料、制备方法和布洛芬片

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5104648A (en) * 1989-02-02 1992-04-14 Mallinckrodt Specialty Chemicals Company High ibuprofen content granulations
GB8920693D0 (en) * 1989-09-13 1989-10-25 Nicholas Kiwi Pty Ltd Non-effervescent ibuprofen compositions
CA2061520C (en) * 1991-03-27 2003-04-22 Lawrence J. Daher Delivery system for enhanced onset and increased potency
GB9224021D0 (en) * 1992-11-16 1993-01-06 Boots Co Plc Effervescent compositions
US6083430A (en) * 1994-10-28 2000-07-04 Fuisz Technologies Ltd. Method of preparing a dosage unit by direct tableting and product therefrom
GB9603699D0 (en) * 1996-02-21 1996-04-17 Boots Co Plc Therapeutic composition
IT1301966B1 (it) * 1998-07-30 2000-07-20 Zambon Spa Composizioni farmaceutiche ad attivita' analgesica

Also Published As

Publication number Publication date
NZ539405A (en) 2006-12-22
UA86751C2 (ru) 2009-05-25
PL376177A1 (en) 2005-12-27
EP1410793B1 (de) 2005-11-16
AU2003266094B2 (en) 2009-04-23
BR0315248A (pt) 2005-08-23
PA8586101A1 (es) 2005-05-10
DE50301661D1 (de) 2005-12-22
DK1410793T3 (da) 2006-04-03
CN1705470A (zh) 2005-12-07
JP2006505558A (ja) 2006-02-16
NO20052343L (no) 2005-06-02
US20040102522A1 (en) 2004-05-27
KR20050083760A (ko) 2005-08-26
CH693586A5 (de) 2003-10-31
CA2500987A1 (en) 2004-04-29
CO5700709A2 (es) 2006-11-30
TW200407175A (en) 2004-05-16
PE20040417A1 (es) 2004-07-14
BRPI0315248B1 (pt) 2016-08-02
MXPA05003592A (es) 2005-09-30
HRP20050429A2 (en) 2005-06-30
MA27490A1 (fr) 2005-08-01
AU2003266094A1 (en) 2004-05-04
EP1410793A1 (de) 2004-04-21
IL167357A (en) 2009-05-04
AR041428A1 (es) 2005-05-18
MY132858A (en) 2007-10-31
TWI262800B (en) 2006-10-01
CN100592909C (zh) 2010-03-03
KR101046894B1 (ko) 2011-07-06
JP4608316B2 (ja) 2011-01-12
ES2249702T3 (es) 2006-04-01
ECSP055793A (es) 2005-08-11
ATE309789T1 (de) 2005-12-15
WO2004035024A1 (en) 2004-04-29
EA007914B1 (ru) 2007-02-27
ZA200502925B (en) 2006-02-22
CH693586A8 (de) 2003-12-15
EA200500649A1 (ru) 2005-10-27

Similar Documents

Publication Publication Date Title
HRP20050429A2 (en) Dosage form of sodium ibuprofen
IL164519A0 (en) Pharmaceutical formulations
EP1560569A4 (en) GASTRORETENTIVE LEVODOPA DELIVERY FORM
AU2003291103A8 (en) Pharmaceutical composition
IL172619A0 (en) Pharmaceutical formulation comprising levothyroxine sodium
EP1425019A4 (en) PHARMACEUTICAL COMPOSITION
AU2003250372A8 (en) Pharmaceutical composition
ZA200500516B (en) Oral Administration of calcitonin
GB2392093B (en) Pharmaceutical formulations
GB0229258D0 (en) Medicinal compositions
GB2387096B (en) Tomography of curved surfaces
HK1081451A1 (en) Medicinal composition
EP1480649A4 (en) STABLE PHARMACEUTICAL COMPOSITIONS
PL355453A1 (en) Pharmaceutical agent
HK1062274A1 (en) Medicinal composition
EP1491189A4 (en) ORAL PHARMACEUTICALS WITH DICLOFENAC SODIUM
HU0200337D0 (en) Stabilised pharmaceutical composition
EP1547593A4 (en) MEDICINAL COMPOSITION
GB0208324D0 (en) Administration of beneficial substances
AU2003202107A1 (en) Stable pharmaceutical composition comprising pravastatin sodium
GB0214885D0 (en) Medicament
GB0211377D0 (en) Medicament
GB0220451D0 (en) Pharmaceutical use
GB0209411D0 (en) Drug delivery
GB0217478D0 (en) Multiple-therapy drug delivery